Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment

dc.contributor.author	Bello López, José Luis
dc.date.accessioned	2017-06-07T07:10:50Z
dc.date.available	2017-06-07T07:10:50Z
dc.date.issued	2013
dc.identifier.issn	0143-3636
dc.identifier.uri	http://hdl.handle.net/20.500.11940/3528
dc.language.iso	eng
dc.title	Predictive value of interim 18F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment
dc.type	Artigo	es
dc.authorsophos	González-Barca, E.
dc.authorsophos	Canales, M.
dc.authorsophos	Cortés, M.
dc.authorsophos	Vidal, M. J.
dc.authorsophos	Salar, A.
dc.authorsophos	Oriol, A.
dc.authorsophos	Bargay, J.
dc.authorsophos	Bello, J. L.
dc.authorsophos	Sánchez, J. J.
dc.authorsophos	Tomás, J. F.
dc.authorsophos	Donato, E.
dc.authorsophos	Ferrer, S.
dc.authorsophos	Caballero, D.
dc.identifier.doi	10.1097/MNM.0b013e328363c695
dc.identifier.isi	323884800002
dc.identifier.pmid	23880897
dc.identifier.sophos	13272
dc.issue.number	10
dc.journal.title	NUCLEAR MEDICINE COMMUNICATIONS
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Hematoloxía clínica
dc.page.initial	946
dc.page.final	952
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	34

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.